Ftse Mib
33.294,96
0,20%
DAX
19.146,17
0,76%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.197,06
-0,32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Acura Pharmaceuticals Inc (CE) (ACUR) Acura Pharmaceuticals Inc (CE) (ACUR) Notizie

ACUR

Acura Pharmaceuticals (CE) (ACUR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ACUR
DataOraFonteTitoloSimboloCompagnia
21/11/202414:32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
04/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/06/202319:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:ACURAcura Pharmaceuticals Inc (CE)
28/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/05/202319:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ACURAcura Pharmaceuticals Inc (CE)
05/01/202322:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/202222:13Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/202218:55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/11/202122:53Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ACURAcura Pharmaceuticals Inc (CE)
01/06/202122:11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ACURAcura Pharmaceuticals Inc (CE)
12/04/202116:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/202122:17Edgar (US Regulatory)Annual Report (10-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
07/08/201920:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ACURAcura Pharmaceuticals Inc (CE)
12/07/201916:02Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/07/201822:09Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ACURAcura Pharmaceuticals Inc (CE)
10/04/201815:42Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/201814:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
22/01/201813:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
27/09/201723:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
03/08/201717:48Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ACURAcura Pharmaceuticals Inc (CE)
28/07/201715:38Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/03/201715:15Edgar (US Regulatory)(25-NSE)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/02/201722:15GlobeNewswire Inc.Acura Pharmaceuticals Common Stock To Trade On The OTCQB MarketUSOTC:ACURAcura Pharmaceuticals Inc (CE)
03/02/201723:17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ACURAcura Pharmaceuticals Inc (CE)
03/01/201722:15GlobeNewswire Inc.Acura Pharmaceuticals Exploring Strategic AlternativesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
18/10/201612:30GlobeNewswire Inc.KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion®  Abuse-Deterrent TechnologyUSOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ACURAcura Pharmaceuticals Inc (CE)
23/03/201622:12Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
09/03/201622:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ACURAcura Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ACUR

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
LDO
Leonardo
BIT
MONC
Moncler
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network